期刊文献+

爱普列特老年人体单次给药药代动力学研究 被引量:1

Pharmacokinetics of Epristeride in Old Male Volunteers
下载PDF
导出
摘要 目的:进行老年人口服10mg爱普列特的单次给药药代动力学试验。方法:用HPLC法测定给药后的血药浓度。结果:测定的主要药代动力学参数为:Cmax=0.18±0.07mg·L-1;T1/2B=5.09±2.73h;AUC=1.85±0.69mg·h·L-1;V(c)/F 38.17±11.15L;Tpeak=2.99±0.49h。结论:爱普列特在老年人体内的药代动力学特性在同剂量下与青年人的一致。 OBJECTIVE: To study the pharmacokinetics of epristeride in old healthy male volunteers. METHODS: The concentrations of epristeride in serum samples were determined by HPLC. RESULTS: The pharmacokinetic parameters obtained in the old volunteers were: Cmax=0.18±0.07mg·L-1;T1/2B=5.09±2.73h;AUC=1.85±0.69mg·h·L-1;V(c)/F 38.17 ±11.15L;Tpeak=2.99±0.49h。 CONCLUSIONS: The pharmacokinetic profile of epristeride in old man was same as in young man with same dose level.
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2000年第6期429-431,共3页 The Chinese Journal of Clinical Pharmacology
关键词 爱普列特 单次给药 药代动力学 前列腺增生 epristeride pharmacokinetics HPLC old people pharmacokinetih
  • 相关文献

参考文献2

二级参考文献5

  • 1[1]Audet. PH., Lamb Y, Jorkasky D, et al. Effect of multiple doses of epristends, a steroid 5a- reductase inhibitor, on serum dihydrotestos- terone in older male subjects. Clin Pharmacol Ther, 1993; 53: 231.
  • 2[2]Johnsonbaugh RE, Cohen BR, McCormack, EM, et al. Effect of fourteen days treatment with epristeride, an uncompetitive 5a- reductase inhibitor. on serum and prostatic testosterone and dihydrotestosterone in men with benign prostatic hyperpiasia. J Urol, 1993; 149: 423a.
  • 3[3]Depre M, Meeter C, Hecken AV, et al. Pharmacodynamics and tolerability of L-654,066, a steroid 5a- reductase inhibitor, in men. Clin Pharmacol Ther, 1992; 52: 409~412.
  • 4[4]Boppana VB, et al. Normal - phase high performance liquid chromto- graphic determination of epristeride, a prestatic steroid 5a- reductase enzyme inhibitor, inhuman plasma. J Chromatogr, 1993; 631: 251~254.
  • 5[5]P.R. Audet. Epristeride, Drugs Future, 1994; 19: 646~650.

共引文献10

同被引文献16

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部